Fabhalta (iptacopan) - Novartis
Long-Term Efficacy and Safety of Iptacopan in Patients with IgA Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1252; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall; No abstract available 
Clinical • Late-breaking abstract • Glomerulonephritis • IgA Nephropathy • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/KW26_LBAs_TitlesAuthors.pdf
 
Brad Rovin; Hernan Trimarchi; Bart D. Maes; Vlado Perkovic; Naoki Kashihara; Hong Zhang; Jonathan Barratt; Katarina Petrovic-Bulatovic; Zenab Attari; Severina Jacinto-Sanders; Annabel R. Magirr; Ronny Renfurm; Thomas Hach; Dana V. Rizk
 
Oct 2, 2026
 
Prev Next